Landscapes / Companies
Krystal Biotech, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
7
in active trials · 9 in all
Trials
8 active
14 since 2021
Drugs7
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Neurotrophic Keratitis | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2027Phase 1/2 trial completes | |||
| Next date | Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Cancer, Melanoma Stage III and 7 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Wrinkles in Decolletage, Pigmentation and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Cystic Fibrosis | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Skin Roughness, Wrinkle and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Alpha 1-Antitrypsin Deficiency | ||||
| Open drug page | |||||
About
- No active trial
- KB105, Topical beremagene geperpavec
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021